featured
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial
JAMA Neurol 2021 Mar 01;78(3)312-320, T Simuni, B Fiske, K Merchant, CS Coffey, E Klingner, C Caspell-Garcia, DE Lafontant, H Matthews, RK Wyse, P Brundin, DK Simon, M Schwarzschild, D Weiner, J Adams, C Venuto, TM Dawson, L Baker, M Kostrzebski, T Ward, G RafaloffFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.